CARL today
$17.12-$0.18 (-1.04%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minSymmetric Triangle
Daily trend turns down below $13.31
Key levels
Resistance$19.15
Support$16.13
Support$14.27
Latest news & SEC filings
AnalystAnalysts revise Carlsmed price targets after Q3 results
EarningsAnalysts raise forecasts on Carlsmed following strong Q3 results
AnalystTruist Securities keeps Buy rating on Carlsmed, lifts price target to $23
AnalystNeedham keeps Buy rating on Carlsmed, lifts price target to $22
All CARL news →About Carlsmed
Carlsmed makes AI-driven personalized spine surgery products. Its aprevo platform pairs planning software with individually designed interbody implants and disposable instruments for fusion of the lumbar and cervical spine. The company supplies hospitals and surgery centers in the United States via its own sales force and independent agents.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
CARLSMED, INC. (CARL)
What Is the Price Target for CARL?
SEPT Low Target
$17.00
SEPT Mid Target
$20.00
SEPT High Target
$24.00
Analyst Consensus
$20.00
Is CARL a Buy or Sell Right Now?
Thesis
- •Revenue growing 85.9% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CARL.
Start Free Trial →Is CARL Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$20.00
30
Moat Score
NONE
5/9
Piotroski Score
3.5
Altman Z-Score
What Is Smart Money Doing with CARL?
Insider Signal
SELLING
1 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Bertolini Jeffrey | officer | Buy | 747 | $4K | Nov 3, 2026 |
| Bertolini Jeffrey | officer | Sale | 747 | $11K | Nov 3, 2026 |
| Bertolini Jeffrey | officer | Buy | 747 | $4K | Oct 5, 2026 |
| Bertolini Jeffrey | officer | Sale | 747 | $11K | Oct 5, 2026 |
| Bertolini Jeffrey | officer | Buy | 243 | $542.38 | Sep 30, 2026 |
| Bertolini Jeffrey | officer | Sale | 243 | $3K | Sep 30, 2026 |
| Heppenstall Richard | officer | Buy | 89,286 | - | Sep 28, 2026 |
| Presidio Management Group XII, L.L.C. | 10% owner | Buy | 200,000 | $3.0M | Jul 24, 2025 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CARL Growth Story
Revenue YoY
85.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
65.3%
FCF Growth YoY
-15.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for CARL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CARL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:08 | $17.04 | 2,700 | $$46K | BUY |
| 20:17:48 | $17.18 | 8,919 | $$153K | MIDPOINT |
| 17:48:07 | $17.24 | 1,300 | $$22K | SELL |
| 17:36:54 | $17.44 | 1,000 | $$17K | SELL |
| 16:54:37 | $17.25 | 1,000 | $$17K | SELL |
5 dark pool trades shown · $$256K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CARLSMED, INC. (CARL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CARL — frequently asked questions
What is CARL stock price today?
CARLSMED, INC. (CARL) is at $17.12, down 1.04% (-$0.18) at the Nov 13, 2026 close.
Why is CARL stock moving today?
Latest CARL news — Nov 11, 2026: Analysts revise Carlsmed price targets after Q3 results · Nov 11, 2026: Analysts raise forecasts on Carlsmed following strong Q3 results
What is the CARL price target?
The average analyst price target for CARL is $20.00, ranging from $17 to $24, based on 5 analysts. Latest: BTIG maintains on Oct 12, 2026.
What do analysts rate CARL?
Analyst ratings for CARL: 1 Buy, 5 Hold, 0 Sell — consensus Hold.
Did CARL beat earnings?
CARL last reported on Aug 5, 2026: EPS -$0.39 vs -$0.40 expected — a beat of 1.5%.
What is CARL's P/E ratio?
CARL trades at a P/E of 135.8 vs a Healthcare average of 17.1.
Does CARL pay a dividend?
CARL does not currently pay a dividend.
How much debt does CARL have?
CARLSMED, INC. reported $15M of debt and $46M of cash (Jun 30, 2026).
What are CARL support and resistance levels?
Support: $16.13, $14.27, $12.05. Resistance: $19.15.
What are insiders doing with CARL?
Insider activity: SELLING, 1 buys and 4 sells in the last 90 days.
What is the latest news on CARL?
Nov 11, 2026: Analysts revise Carlsmed price targets after Q3 results · Nov 11, 2026: Analysts raise forecasts on Carlsmed following strong Q3 results · Nov 11, 2026: Truist Securities keeps Buy rating on Carlsmed, lifts price target to $23